Delivery Order SPE2DB25D3306-SPE2DB26FUANX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hysingla ER 40 mg tablets (60-count units) with a ceiling value of $1,362.27. This firm fixed-price delivery order, awarded on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a competitively awarded non-set-aside contract. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Hysingla ER 40 mg tablets (60-count units) with a contract value of $1,306.23. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery is scheduled for completion by October 21, 2025,...
- The Defense Logistics Agency awarded a delivery order valued at $1,725.21 to AmerisourceBergen Drug Corp for HYSINGLA ER 20 mg tablets (60-count) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The award was made on...
- This federal contract award, valued at $7,177.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hysingla ER 30 mg tablets, a medication used for pain management. This contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Hysingla ER 60 mg tablets. The Delivery Order has a firm fixed price of $1,163.38 and an ultimate completion date of July 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of...
- This federal contract award is for the delivery of HYSINGLA ER 30 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $1,499.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 13, 2025, with a performance period ending on May 14, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency Troop Support Medical awarded a $233,930 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561487735 Hysingla ER 20 mg tablets. Under this contract, Amerisourcebergen will deliver 60 tablets to a location in Conshohocken, Pennsylvania by July 13, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring pharmaceuticals and other medical supplies to support troops. No...
- This federal contract award, identified as SPE2DX15D3306|SPE2DX24FAEVF, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of HYSINGLA ER 20 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,382.62 and a period of performance through April 2, 2024. This delivery order contract is a firm fixed price arrangement, with no set-aside designation used....
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of HYSINGLA ER 40 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,635.51 and a performance period through April 11, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC)...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation and a leading global pharmaceutical distributor. The contract, valued at $1,163.38, is for the delivery of HYSINGLA ER 60 MG TABLET 60S, a specialty pharmaceutical product. This order falls under a larger $999,999,999.00 indefinite delivery contract that AmerisourceBergen Drug Corp holds with DLA to provide a...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUANXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,887.98 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Hysingla ER 20 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp leverages this comprehensive vehicle to supply pharmaceutical products and medical supplies to support military healthcare systems and other federal customers globally. The Hysingla ER delivery represents a routine medical supply fulfillment consistent with the company's extensive portfolio of opioid pain management medications and other therapeutics supplied through federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/30/25 |